VERU INC. Effective Income Tax Rate Reconciliation Gilti Percent
VERU INC. (VERU) reported Effective Income Tax Rate Reconciliation Gilti Percent of -1.40% for the 12-month period ending 2024-09-30, per its 10-K filed 2024-12-16.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationGiltiPercent · last filed 2024-12-16
- VERU INC. effective income tax rate reconciliation gilti percent for fiscal 2024 was -1.40%.
- VERU INC. effective income tax rate reconciliation gilti percent for fiscal 2023 was 0.00%.
| Period end | Effective Income Tax Rate Reconciliation Gilti Percent 12 month |
|---|---|
| 2024-09-30 | -1.40% 10-K · filed 2024-12-16 |
| 2023-09-30 | 0.00% 10-K · filed 2024-12-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |